Navigation Links
Wyeth Chairman Robert Essner Announces June 27 Retirement
Date:4/24/2008

- Bernard Poussot to Become Chairman of the Board -

MADISON, N.J., April 24 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE) today announced that its Chairman, Robert Essner, 60, has decided to retire from the Company effective June 27, 2008. Mr. Essner has held the position of Chairman since January 2003 and served as Wyeth's Chief Executive Officer from 2001 to 2007. The Company's Board of Directors has elected Bernard Poussot, Wyeth's President and Chief Executive Officer, to the additional position of Chairman, effective June 27, 2008.

Today's announcement is the culmination of a succession plan that began in April 2006 when Mr. Poussot was promoted to President and Vice Chairman. In January 2007, he was named President and Chief Operating Officer and was elected to the Company's Board of Directors. He became CEO on January 1, 2008.

"We thank Bob for his outstanding contributions in leading our Company," said John P. Mascotte, Chairman of the Wyeth Board's Nominating and Governance Committee. "Bob and Bernard have been a great team for many years, and this type of well-planned succession is in the best interests of the Company, its employees and stockholders."

"Bob successfully led Wyeth's transformation from a holding company to what is now a world leader in pharmaceuticals that has grown in annual revenue from $14 billion in 2001 to more than $22 billion in 2007," said Mr. Poussot. "During his tenure, Wyeth became a leader in biotechnology and thanks to his commitment, we now have one of the most extensive Alzheimer's programs in the health care industry."

"It has been an honor and privilege to lead Wyeth's rise to its current position in the top-tier of the pharmaceutical industry," said Mr. Ess
'/>"/>

SOURCE Wyeth
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
2. Wyeth to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
3. Wyeth Sets Webcast And Conference Call For 2008 First Quarter Earnings
4. Wyeth To Appeal Arkansas Hormone Therapy Trial Verdicts
5. Wyeth Pharmaceuticals Ends Collaboration Agreements with Solvay Pharmaceuticals for Bifeprunox and Other Compounds
6. Wyeth Announces Executive Change in Finance Organization
7. Wyeth Announces Election of Timothy P. Cost as Senior Vice President, Corporate Affairs
8. Wyeth to Present at the Merrill Lynch 2008 Global Pharmaceutical, Biotechnology and Medical Device Conference
9. Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year
10. Wyeth Consumer Healthcare Supports U.S. Food and Drug Administration Decision for Over-the-Counter Cough and Cold Medications in Children under Two Years of Age
11. Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals Launch of Generic Pantoprazole in Violation of PROTONIX Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... SC (PRWEB) October 22, 2014 ... of its cardiovascular pharmacogenetics menu, which enables healthcare ... outcomes. With PCLS’s evidence-based results, healthcare providers ... and optimize their therapy, while minimizing risks for ... the U.S., according to the FDA [1] more ...
(Date:10/22/2014)... /PRNewswire/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ... its Oral Amphotericin B program.  The company recently ... work involving samples from HIV/AIDS patients exposed ... pre clinical studies and regulatory filings to move ... utilizing approximately $700,000 of funding and technological advice ...
(Date:10/22/2014)... DIEGO and HONG KONG ... innovative rare disease therapeutics enterprise, announced today that rare ... the company as vice president, research. Dr. McKew brings ... including key leadership positions at the National Institutes of ... its acquisition by Wyeth). Dr. McKew will lead aTyr,s efforts ...
(Date:10/20/2014)... October 20, 2014 Convey Computer ... a team from Iowa State University won first place ... Using a Convey HC-2ex, the team’s solution achieved the ... faster than the second place finisher. , Experts from ... upon the month long challenge, using a variety of ...
Breaking Biology Technology:PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 3aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 2Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 3
... Indoor spraying with the insecticide bendiocarb has dramatically decreased ... that insecticides remain a potent weapon for fighting malaria ... an entire class of mosquito-killing compounds, according to a ... The American Journal of Tropical Medicine and Hygiene ...
... Texas, Oct. 5, 2011 Luminex Corporation (NASDAQ: ... the National Marrow Donor Program – Be The Match to ... the chances of finding a match for the growing number ... 100 Luminex employees joined the National Marrow Donor Registry in ...
... ANN ARBOR, Mich., Oct. 5, 2011 Adeona Pharmaceuticals, Inc. ... medicines for serious central nervous system diseases, announced today that ... and Chairman, will provide a brief update on its Alzheimer,s ... of four featured companies at the invitation-only event on Tuesday ...
Cached Biology Technology:Scientists determine alternative insecticide dramatically reduces malaria transmission 2Scientists determine alternative insecticide dramatically reduces malaria transmission 3Scientists determine alternative insecticide dramatically reduces malaria transmission 4Luminex Corporation Joins Forces With the National Marrow Donor Program - Be The Match® 2Luminex Corporation Joins Forces With the National Marrow Donor Program - Be The Match® 3Luminex Corporation Joins Forces With the National Marrow Donor Program - Be The Match® 4Adeona CEO to Present at the NYC Medtech Forum 2
(Date:10/17/2014)... release is available in German . ... a very few drugs. When treating overdoses, doctors are often ... especially difficult if there is a combination of drugs involved. ... and accidentally swallows his grandmother,s pills? ETH professor Jean-Christophe Leroux ... to find an answer to this question. "The task was ...
(Date:10/16/2014)... Virginia Institute of Marine Science have received a ... to identify the streams and wetlands most vulnerable ... help local governments and citizens conserve these important ... dataset of tidal-marsh observations first gathered by VIMS ... baseline can today,s researchers accurately map the slow ...
(Date:10/16/2014)... thinking on how the bowel lining develops and, in ... cancer starts. , The researchers produced evidence that stem ... that are a feature of the bowel lining, and ... development, a controversial finding as scientists are still divided ... technologies, Dr Chin Wee Tan and Professor Tony Burgess ...
Breaking Biology News(10 mins):Emergency aid for overdoses 2Emergency aid for overdoses 3EPA grant will help localities conserve headwater wetlands 2EPA grant will help localities conserve headwater wetlands 3Cryptic clues drive new theory of bowel cancer development 2
... today center for discovery, economic growth engine, innovation hub, ... prepared for the challenges that lie ahead? , Is America ... , People are our greatest asset how do we ... the fiscal crisis on America,s research enterprise? , , ...
... 2012. Researchers from the University of Maryland School of ... bone marrow in mice to help create tissue cells of ... a scientific step they hope may lead to potential new ... Parkinson,s or Alzheimer,s. The research in collaboration with the University ...
... July 3, 2012 Exposure to childhood maltreatment increases ... many negative consequences of these conditions. This new ... University, Canada, provides important insight into one of the ... expanded our previous work on the epigenetic regulation of ...
Cached Biology News:All Things Research 2012 roundtable discussion 2Study results: Adult stem cells from bone marrow 2Highlighting molecular clues to the link between childhood maltreatment and later suicide 2
... Analysis Note: The kit contains all the ... determination of NADPH-cytochrome c reductase activity in ... microsomes [endoplastic reticulum (ER)]. It has been ... such as liver, kidney, brain, spleen, and ...
... Strain Competent Cell Sets Sets of ... combinations The most common method ... coli is to use chemically competent ... in the laboratory, greater efficiency, reproducibility and ...
The Saturn 2200 answers your GC/MS questions with the CP-3800 GC and the 2000 Series Ion Trap MS! These components create a platform for the worlds most versatile GC and flexible MS. Both deliver une...
... DNA Methylation Kit uses a simplified procedure ... methylation analysis. The kit is based on ... between cytosine and sodium bisulfite where cytosine ... Methylation Kits innovative in-column desulphonation reaction eliminates ...
Biology Products: